[Chronic pyoderma caused by beta-lactamase-producing strains of Staphylococcus].
Features of the agent structure have been revealed on a subcellular level in vitro and in vivo in the patients with chronic pyodermas induced by Staphylococcus beta-lactamase-producing strains, and the type of these strains interaction with phagocytes before and in the course of combined therapy detected. Regularities in morphologic manifestations of pyoderma development were singled out, explained by specific features of cellular exudate composition and interactions between bacteria and eukaryotes.
S A
SA
Masiukova
T T
TT
Shakhabiddinov
Kh K
KhK
Shadyev
G A
GA
Dmitriev
V V
VV
Delektorskiĭ
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006801:Humans; D008854:Microscopy, Electron; D011711:Pyoderma / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D013210:Staphylococcus / Q000201:enzymology* / Q000302:isolation & purification / Q000648:ultrastructure; D013997:Time Factors; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D001618:beta-Lactamases
Khronicheskaia piodermiia, obuslovlennaia beta-laktamazoprodutsiruiushchimi shtammami stafilokokka.